Colon News and Research

RSS

Biomoda appeals N.M. congressional delegation to support Lung Cancer Mortality legislation

Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) today urged the New Mexico congressional delegation to support the Lung Cancer Mortality Reduction Act of 2009, which calls for a comprehensive federal program to achieve a 50% reduction in the mortality rate of lung cancer by 2016.

3 Dec 2009

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.

3 Dec 2009

New study links cigarette smoking with colorectal cancer

New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for other risk factors.

3 Dec 2009

Patient enrollment complete in Peregrine Pharmaceuticals' Cotara trial

Peregrine Pharmaceuticals, Inc. today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with relapsed glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara is a targeted monoclonal antibody linked to a radioisotope being developed as a potential new treatment for GBM.

2 Dec 2009

Saint Louis University Hospital performs one of the first total abdominal colectomies

Building upon the momentum and success of its rapidly growing single-incision laparoscopic surgery program, Saint Louis University Hospital recently performed one of the first total abdominal colectomies, including reconstruction of the intestinal tract by reconnection of the remaining small intestine to the rectum, via single-incision laparoscopy.

2 Dec 2009

Cancer Prevention Research Conference highlights new research on cancer

The American Association for Cancer Research Frontiers in Cancer Prevention Research Conference will focus on the latest biological, medical and social research behind cancer prevention.

2 Dec 2009

CT imaging combined with Avastin may predict overall survival in metastatic colorectal cancer

Using routine computed tomography (CT) imaging to analyze form and structural changes to colorectal liver metastasis after bevacizumab and chemotherapy may predict overall survival, according to research from The University of Texas M. D. Anderson Cancer Center.

2 Dec 2009

Surgeons remove rectal mass using innovative surgical approach

Performing surgical operations without leaving scars has ceased to be a chimera and has become a reality. This is demonstrated by the recent surgical advances made using NOTES (Natural Orifice Transluminal Endoscopy Surgery), an innovative surgical approach that allows surgical access using the body's natural orifices.

2 Dec 2009

Cancer researchers find a way to turn ineffective new cancer drugs into cancer-fighters

Cancer researchers at the University of Oklahoma Health Sciences Center have found a way to turn ineffective new cancer drugs into cancer-fighters. By using their patented chemical compound, SHetA2, researchers tricked cancer cells into responding to new treatments and undergoing cell suicide.

2 Dec 2009

TGF--1 suppresses the growth of cancer cells, find researchers

UT Southwestern Medical Center researchers have found that a naturally occurring protein -- transforming growth factor beta1 (TGF--1) -- which normally suppresses the growth of cancer cells, causes a rebound effect after a prolonged exposure.

2 Dec 2009

MicroDose Therapeutx acquires a portfolio of compounds from Epix Pharmaceuticals

MicroDose Therapeutx Inc. today announced that it has acquired a portfolio of compounds for the potential treatment of chronic constipation, irritable bowel syndrome with constipation (IBS-C) and other diseases, from Epix Pharmaceuticals, Inc. (EPIX) (Lexington, MA).

2 Dec 2009

MAbs for early detection of cancer

Two sets of recommendations issued earlier this month have revised longstanding guidelines concerning the age at which women should first be tested for breast and cervical cancer and how frequently.

1 Dec 2009

Researchers devise a way to deliver right therapy directly to tumors using aptamers

Finding and treating a tumor without disturbing normal tissue presents challenges - sometimes the most effective therapies can be invasive and harsh.

1 Dec 2009

Cell Therapeutics' platinum-based anti-tumor compounds demonstrate stronger anti-tumor potency

Cell Therapeutics, Inc. (CTI) announced today that its new class of platinum-based anti-tumor compounds, termed bis-platinates, demonstrated a stronger anti-tumor potency and activity compared to currently available platinum-based compounds as well as the ability to overcome cisplatin-resistance in cancer cell lines.

30 Nov 2009

CCAC congratulates the Ontario government for expanding access to Avastin

The Colorectal Cancer Association of Canada (CCAC) applauds the Ontario Ministry of Health and Long-Term Care's decision today to provide expanded access of Avastin (bevacizumab) to patients with metastatic colorectal cancer.

30 Nov 2009

LCA-CA issues 2nd Annual Report Card on Lung Cancer

Today, Lung Cancer Alliance-California (LCA-CA) issued its 2nd Annual Report Card on Lung Cancer. The 2009 Report Card is an assessment of progress being made against this lethal disease in the state of California.

26 Nov 2009

LCA-GA issues 4th Annual Report Card on Lung Cancer

Today, Lung Cancer Alliance-Georgia (LCA-GA) issued the 4th Annual Report Card on Lung Cancer. This Report is an assessment of progress being made against this lethal disease in the state of Georgia.

26 Nov 2009

Wnt and EGFR signaling pathways interact to promote tumor cell invasion and metastasis

Two signaling pathways essential to normal human development - the Wnt/Wingless (Wnt) and epidermal growth factor receptor (EGFR) pathways - interact in ways that can promote tumor cell invasion and metastasis, researchers from The University of Texas M. D. Anderson Cancer Center report in the Nov. 25 issue of Molecular Cell.

26 Nov 2009

'Suicide gene E' reduces potent drug dosage in cancer patients

Researchers at the University of Granada have found a suicide gene, called 'gene E', which leads to the death of tumour cells derived from breast, lung and colon cancer, and prevents their growth. The importance of this new gene is that its use to fight cancer can reduce the potent drugs that are currently used, so that could mean more effective treatment for cancer.

25 Nov 2009

New Brunswick's colorectal cancer screening program lauded by CCAC

The Colorectal Cancer Association of Canada (CCAC) applauds the decision of the New Brunswick's Minister of Health Mary Schryer to implement a province wide colorectal cancer screening program and to provide funding for Avastin (bevacizumab) for patients with metastatic colorectal cancer.

25 Nov 2009

Colon News and Research

Biomoda appeals N.M. congressional delegation to support Lung Cancer Mortality legislation

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

New study links cigarette smoking with colorectal cancer

Patient enrollment complete in Peregrine Pharmaceuticals' Cotara trial

Saint Louis University Hospital performs one of the first total abdominal colectomies

Cancer Prevention Research Conference highlights new research on cancer

CT imaging combined with Avastin may predict overall survival in metastatic colorectal cancer

Surgeons remove rectal mass using innovative surgical approach

Cancer researchers find a way to turn ineffective new cancer drugs into cancer-fighters

TGF--1 suppresses the growth of cancer cells, find researchers

MicroDose Therapeutx acquires a portfolio of compounds from Epix Pharmaceuticals

MAbs for early detection of cancer

Researchers devise a way to deliver right therapy directly to tumors using aptamers

Cell Therapeutics' platinum-based anti-tumor compounds demonstrate stronger anti-tumor potency

CCAC congratulates the Ontario government for expanding access to Avastin

LCA-CA issues 2nd Annual Report Card on Lung Cancer

LCA-GA issues 4th Annual Report Card on Lung Cancer

Wnt and EGFR signaling pathways interact to promote tumor cell invasion and metastasis

'Suicide gene E' reduces potent drug dosage in cancer patients

New Brunswick's colorectal cancer screening program lauded by CCAC

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News